NVCR
NASDAQ HealthcareNovoCure Limited - Ordinary Shares
Medical Devices
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax. The company also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.
�� 市场数据
| 价格 | $12.83 |
|---|---|
| 成交量 | 1,366,158 |
| 市值 | 1.46B |
| 贝塔系数 | 0.820 |
| RSI（14日） | 68.5 |
| 200日均线 | $12.77 |
| 50日均线 | $11.78 |
| 52周最高 | $20.06 |
| 52周最低 | $9.82 |
| Forward P/E | -11.01 |
| Price / Book | 4.24 |
🎯 投资策略评分
NVCR 在各投资策略中的评分。分数越高，越符合该策略目标。
🔍 策略解读
最佳匹配： 🔪 Falling Knife (61/100) — 此策略 逆向投资（超卖 + 低于移动均线）.
评分最低的策略： 🐋 Institutional Whale (33/100). 单一评分不构成买入或卖出信号 — 请结合多种视角综合判断。 了解如何解读这些评分 →
📚 了解更多
在文本中查找 NVCR in your text
粘贴任何文章、记录或帖子 — 工具将提取 NVCR 以及每一个其他隐藏的股票代码。
免责声明：本数据仅供教育和娱乐用途，不构成金融建议。市场数据可能存在延迟。在做出投资决策之前，请始终进行自己的研究。
数据最后更新： 2026-04-17.